Viewing StudyNCT00392392



Ignite Creation Date: 2024-05-05 @ 5:09 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00392392
Status: COMPLETED
Last Update Posted: 2013-09-20
First Post: 2006-10-25

Brief Title: Preoperative Bevacizumab and Trastuzumab With ABI-007 and Carboplatin in HER2 Breast Cancer
Sponsor: SCRI Development Innovations LLC
Organization: SCRI Development Innovations LLC

Conditions & Keywords Data

Conditions:
Name
Breast Cancer
Keywords:
Name View
Breast Cancer View